The World of Health & Medicine News

Your daily orange juice could be helping your heart

Your daily orange juice could be helping your heart

Most of us think of orange juice as a simple breakfast habit, something you pour without much thought. Yet scientists are discovering that this everyday drink may be doing far more in the body than quenching thirst.

A recent study has shown that regular orange juice consumption can influence the activity of thousands of genes inside our immune cells. Many of these genes help control blood pressure, calm inflammation and manage the way the body processes sugar, all of which play an important role in long-term heart health.

The study followed adults who drank 500ml of pure pasteurized orange juice every day for two months. After 60 days, many genes associated with inflammation and higher blood pressure had become less active.

These included NAMPT, IL6, IL1B and NLRP3, which usually switch on when the body is under stress. Another gene known as SGK1, which affects the kidneys’ ability to hold onto sodium (salt), also became less active.

Such changes match previous findings that daily orange juice drinking can reduce blood pressure in young adults.

This is noteworthy because it offers a possible explanation for why orange juice has been linked to better heart health in several trials. The new work shows that the drink does not simply raise blood sugar. Instead, it appears to trigger small shifts in the body’s regulatory systems that reduce inflammation and help blood vessels relax.

Natural compounds in oranges, particularly hesperidin, a citrus flavonoid known for its antioxidant and anti-inflammatory effects, seem to influence processes related to high blood pressure, cholesterol balance and the way the body handles sugar.

The response also varies by body size. People carrying more weight tended to show greater changes in genes involved in fat metabolism, while leaner volunteers showed stronger effects on inflammation.

 

spot_img

Explore more

spot_img

GSK enters lung cancer drug market with early FDA nod for...

GSK enters lung cancer drug market with early FDA nod for Jideytro GSK (GSK.L), opens new tab said on Wednesday the U.S. FDA approved its drug ​to...

Working from home could be harming your health, warns Chris Whitty

Working from home could be harming your health, warns Chris Whitty England’s chief medical officer has issued a warning about the health dangers of prolonged sitting, coinciding...

Popular sugar substitutes linked to faster brain aging

Popular sugar substitutes linked to faster brain aging Several popular sugar substitutes may not be as harmless as they seem. Adults who consumed the most...

 The Best Time to Eat Peaches for Energy, According to a...

The Best Time to Eat Peaches for Energy, According to a Dietitian Peaches are a juicy, naturally sweet, nutritious, and refreshing fruit. While there’s no...

FDA approves at-home starter dose of Eisai-Biogen Alzheimer’s drug

FDA approves at-home starter dose of Eisai-Biogen Alzheimer's drug The U.S. FDA on Monday approved an at-home starting dose of Eisai's (4523.T), opens new tab and Biogen's (BIIB.O),...

The One Healthy Food That Might be Spiking Your ‘Bad’ Cholesterol

The One Healthy Food That Might be Spiking Your 'Bad' Cholesterol Coconut oil has enjoyed a long run as a wellness favorite. It's been blended...

US FDA approves Vertex’s gene therapy for sickle cell disease in...

US FDA approves Vertex's gene therapy for sickle cell disease in children as young as two The U.S. Food and Drug Administration approved expanded use...

FDA clears Orca’s blood cancer therapy to reduce stem cell transplant...

FDA clears Orca's blood cancer therapy to reduce stem cell transplant complications The U.S. Food and Drug Administration said on ​Tuesday it has approved Orca...